3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Gynecologic
1
Genitourinary
1
Conditions
Breast Neoplasms
36
Neoplasms
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm Metastasis
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
3
Lymphoma, Mantle-Cell
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Advanced Breast Cancer
3
Sarcoma
2
Recurrence
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Inflammation
2
Hereditary Sensory and Autonomic Neuropathies
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thrombosis
1
Thromboembolism
1
Thrombocytosis
1
Squamous Cell Carcinoma of Head and Neck
1
Primary Myelofibrosis
1
Oligodendroglioma
1
Neoplasms, Neuroepithelial
1
Myeloproliferative Disorders
1
Interventions
palbociclib
2
salicylsalicylic acid
1
Sevoflurane
1
Rivaroxaban
1
Propofol
1
Bevacizumab
1
Ashwagandha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Inflammation
×
palbociclib
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled